Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 01 through its relevant journals, 05 Conferences, 07 Workshops are presently dedicated exclusively to Hormone Replacement Therapy and about 03 articles are being published on Hormone Replacement Therapy.
Hormone Replacement Therapy refers to any form of hormone therapy wherein the patient, in the course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Common forms of hormone replacement therapy include:
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Hormone Replacement Therapy Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Hormone Replacement Therapy Conference offers excessive quality content to suit the diverse professional development all over the globe. It is a perfect platform to discuss the current discoveries and developments in the field of Hormone Replacement Therapy.
To avoid HRT risks it is essential to use the most effective delivery method of both estrogen and progesterone. Bioidentical estradiol (estrogen) when taken orally is converted in the liver to estrone, a weaker bioidentical estrogen. However when estrogen as estradiol is used transdermally as a patch, gel, or pessary, it enters the bloodstream as bioidentical estradiol. When estrogen is ingested it is subjected to first pass metabolism (Phase I drug metabolism) and is processed through the liver. This first pass metabolism stimulates proteins associated with heart disease and stroke, such as C-reactive protein, activated protein C, and clotting factors. Using a patch, gel or pessary to take estrogen avoids first pass metabolism and the risks associated with it and the same level of blood concentration can be achieved avoiding the serious side effects associated with oral estradiol HRT. Current research shows that the transdermal route of estradiol administration can also be advantageous for women with diabetes, hypertension and other cardiovascular risk factors, as those risks increase with advancing age.[7] Women taking bioidentical estrogen, orally or transdermally, who have a uterus must still take an FDA-approved progestin or micronized progesterone to lower the risk of endometrial cancer. The natural, plant-derived progesterone creams sold over the counter contain too little progesterone to be effective. Wild yam (Dioscorea villosa) extract creams are not effective since the natural progesterone present in the extract is not bioavailable.
• Hormone replacement therapy for menopause is based on the idea that the treatment may prevent discomfort caused by diminished circulating estrogen and progesterone hormones, or in the case of the surgically or prematurely menopausal, that it may prolong life and may reduce incidence of dementia. It involves the use of one or more of a group of medications designed to artificially boost hormone levels. The main types of hormones involved are estrogens, progesterone or progestins, and sometimes testosterone. It often referred to as "treatment" rather than therapy.
• Hormone replacement therapy for transgender people introduces hormones associated with the gender that the patient identifies with (notably testosterone for trans men and estrogen fortrans women). Some intersex people may also receive HRT. Cross-sex hormone treatment for transgender individuals is divided into two main types: hormone replacement therapy (female-to-male) and hormone replacement therapy (male-to-female).
• Androgen replacement therapy (andropausal and ergogenic use) is a hormone treatment often prescribed to counter the effects of male hypogonadism. It is also prescribed to lessen the effects or delay the onset of normal male aging. Additionally, androgen replacement therapy is used for men who have lost their testicular function to disease, cancer, or other causes.
Past research has highlighted potential risks of HRT however the principal results from the Women's Health Initiative Randomized Controlled Trial concluded that estrogen in combination with micronized progesterone is not associated with an increased risk of breast cancer.
Market Analysis:
As recently as 2005 women have had a positive attitude towards hormone replacement therapy but based on the empirical data these attitudes may be overly optimistic. There is still much to learn about how HRT affects people. In the combined hormone trial, the WHI tested only one estrogen (Premarin) and one progestin (Provera), in a single pill (Prempro), at a single dose (0.625 mg Premarin and 2.5 mg Provera). Therefore the results are not reliable or representative.
List of Best International Conferences:
• Healthcare Conference
October 05-07, 2015 New Delhi, India
• 4th Nursing and Healthcare Conference
October 05-07, 2015 San Francisco, USA
• 4th Nutrition Conference
October 26-28, 2015 Chicago, Illinois, USA
• 4th Orthopedics and Rheumatology Conference
October 26-28, 2015 Baltimore, Maryland, USA
• Herbals and Natural Remedies Conference
October 26-27, 2015 Chicago, USA
• 6th Diabetes Summit
November 02-04, 2015 Dubai, UAE
• Healthcare Conference
November 09-11, 2015 Dubai, UAE
• 6th Dental Congress
November 23-25, 2015 Bengaluru, India
•3rd HIV/AIDS, STD’s and STL’s Conference
November 30-December 02, 2015, Atlanta, USA
• Public Health and Nutrition Conference
March 10-12, 2016, Madrid, Spain
• 4th Euro Obesity and Endocrinology Specialists Conference
March 28-30, 2016 Valencia, Spain
• 5th Family Nursing Conference
June 13-15, 2016 Philadelphia, USA
• 2nd Retroviruses and Novel Drugs Conference
June 30-July 01, 2016 Cape Town, South Africa
• 6th Obesity Specialists and Endocrinologist Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia
• Health Economics Summit
July 25-26, 2016 Berlin, Germany
• 7th Euro Healthcare and Fitness Conference
September 26-28, 2016 London, UK
• 6th Nursing and Healthcare Conference
October 17-19, 2016 Baltimore, USA
• 4th Epidemiology and Public Health Conference
October 03-05, 2016 London, United Kingdom
• 7th Nursing and Healthcare Conference
October 17-19, 2016 Baltimore, USA
• Bio-Identical Hormone Replacement Therapy Conference
• The Canadian Menopause Consensus Conference
• NAMS 25th Annual Meeting
• BHRT Symposium
• 85th Annual Meeting of the Endocrine Society
• Endocrinology Conference
• The first clinical synthesis conference on hormone replacement therapy
Relevant Societies and Associations:
• Parsemus Foundation
• American Cancer Society
• International Menopause Society
• National Osteoporosis Society
• National Health Service
• Australasian Menopause Society
• North American Menopause Society
• Canadian Cancer Society
• National Health and Medical Research Council
• Society of Obstetricians and Gynaecologists of Canada
• The Endocrine Society
• Blue Cross Blue Shield Association
Companies:
• United States Preventive Services Task Force
• Institute for Functional Medicine
• National Cancer Institute
• Food and Drug Administration
• Australian Broadcasting Corporation
• United States National Library of Medicine
• Novo Nordisk
• Hormone Health and Weight Loss
List of Related Journals:
This page will be updated regularly.
This page was last updated on December 23, 2024
